COMPANY
History
- 2020's
- 2010's
- 2000's
2020's
- 2023
- 01
the inauguration of the new CEO"
- 2022
- 03
Market launch of new product - Viral Transport Medium (VTM)
- 03
Market launch of new product - Saliva DNA Collector
- 03
Market launch of new product - Influenza A/B Kit
- 09
Indonesia-Korea Future Industry Business Plaza 2022"
- 2021
- 04
Acquired ISO 13485:2016 certification
- 04
Completion/Opening of INSOL Logistics Center
- 05
Relocation of corporate headquarters
- 06
Market launch of Wartfreezer (cryosurgical device)
- 07
Created TFT for metaverse platform integration & utilization
- 2020
- 05
Selected as host organization for “Eurostars-2,” international collaborative research project sponsored by Ministry of Trade, Industry and Energy (MOTIE)
- 05
Selected as host organization for “Bioindustry Core Project” sponsored by Ministry of Trade, Industry and Energy (MOTIE)
- 09
Acquired GMP certification for IVD medical devices
2010's
- 2019
- 06
Selected as “Strong & Small Enterprise for Work-Life Balance” by City of Seoul
- 07
Certified as “Main Biz” (Management Innovation Business) by Ministry of SMEs and Startups (MSS)
(www.mainbiz.go.kr) - 08
Acquired GMP Certificate for “Medical Device Manufacturing & Quality Management Standard Conformity”
- 11
Selected as participant organization for “Infectious Disease Crisis Response Technology Development” program led by Ministry of Health and Welfare (MOHW)
- 12
Selected as “Outstanding Enterprise for Job Creation” by Seoul Business Agency (SBA)
- 2018
- 09
Acquired business license for medical device manufacturing. Established medical device manufacturing facility.
- 12
Completion/Opening of INSOL GMP Factory
- 12
Selected as “2019 Young-Adult-Friendly Enterprise” by Ministry of Employment and Labor (MOEL)
- 2017
- 09
Sponsored “Water Wells for Africa” program in Zambia
- 12
Business partnership agreement with Korea Basic Science Institute (KBSI)
- 12
Selected as “2018-2020 Small/Medium-Sized Enterprise for Talent Development” by Ministry of SMEs and Startups (MSS)
- 2016
- 03
Received “The 2016 Customer-Loving Brand Award ? Grand Prize” from JoongAng Daily
- 12
Signed agreement with Good Neighbors International (NGO) for “Good_Buy” campaign participation
- 12
Certification/Opening of INSOL R&D Center
- 2015
- 04
Launched INSOL mall (insolmall.co.kr) & OraQuick brand site (oraquick.co.kr)
- 05
Market launch of OraQuick HIV Self-Test
- 11
New Health Technology (nHT) designation granted for QED A-150 by Ministry of Health and Welfare (MOHW)
- 2014
- 02
Exclusive distribution agreement with DNA Genotek (Canada)
- 09
Product supply agreement with Genoplan
- 2013
- 07
Development of OraQuick Auto Transmission System (in collaboration with Asan Medical Center)
- 2012
- 07
Sales partnership agreement with Hyundai Pharmaceutical
- 09
“Non-reimbursement” code published by Ministry of Health and Welfare (MOHW) for INSOL-OraQuick HCV Rapid Antibody Test
- 2011
- 03
Conducted multi-site clinical trial (local bridging study) for OraQuick HCV Rapid Antibody Test
- 10
New Health Technology (nHT) designation granted for OraQuick HCV Rapid Antibody Test by Ministry of Health and Welfare (MOHW)
- 2010
- 08
Completion of research project for Korea Disease Control and Prevention Agency (KDCPA)
- 11
Supplied Histofreezers (cryosurgical devices) to the Korean military
2000's
- 2008
- 05
New Health Technology (nHT) designation granted for OraQuick ADVANCE Rapid HIV-1/2 Antibody Test by Ministry of Health and Welfare (MOHW)
- 07
“Non-reimbursement” decision made by Health Insurance Review & Assessment Service (HIRA) for medical services rendered through OraQuick ADVANCE Rapid HIV-1/2 Antibody Test
- 07
“eSTIM” registered as official trademark by Korean Intellectual Property Office (KIPO)
- 2007
- 03
Acquisition of business license for medical device import
- 04
Market launch of Histofreezer (cryosurgical device)
- 05
Market launch of OraQuick ADVANCE Rapid HIV-1/2 Antibody Test
- 10
Launched eSTIM program & website (www.estim.co.kr) for early testing of sexually transmitted infections (STIs)
- 2006
- 02
Exclusive distribution agreement with OraSure Technologies (USA)
- 02
Certification for KGSP (Korea Good Supplying Practice)
- 03
Market launch of GIL Thiotepa
- 09
MFDS regulatory approval for OraQuick ADVANCE Rapid HIV-1/2 Antibody Test
- 09
Business name changed to Innovative Medical Solutions Co., Ltd. (INSOL)
- 2005
- 04
Collaborative partnership agreement with C.H.A (Japan)
- 10
Supply agreement with Bedford Laboratories (USA)
- 10
MFDS regulatory approval for Thiotepa (anti-cancer chemotherapy drug)
- 2004
- 07
Global In-Licensing USA (GIL USA) established
- 12
Global In-Licensing Korea Co., Ltd. (GIL Korea) established
